Minister of Health visits Lichtenheldt

On the occasion of the planned development of a medical care center in Wahlstedt, representatives of the state of Schleswig-Holstein paid a short visit to the town of Wahlstedt, the investor and our company on [...]

  • Dr. Armin Jentsch

Lichtenheldt with new management

On 1 February, the management team was reorganised with Dr. Armin Jentsch. Dr. Armin Jentsch has taken over the management of the commercial areas as well as sales. We look forward to working with him [...]

CPhI 2021 in Milan

As an exhibitor at this year's CPhI trade show in Milan, we were pleased to have personal contact with numerous visitors and interested parties. Intensive discussions with business partners as well as high-quality consultations on [...]

  • FDA approved

FDA Approval for Lichtenheldt

Lichtenheldt produces a drug with a novel therapeutic principle for a rare but very serious disease. In preparation for FDA approval under the accelerated procedure as an "orphan drug", Lichtenheldt was approved by the FDA.

  • Compounding Center Werkbank

New Compounding Center

After 8 months of construction, the Compounding Center was put into operation in June 2021. This enlarged the production area for bulk production by 440 m² and meets the most modern requirements. With the help [...]

Contact Person:

04554 90 70 0